LoadingLoadingLoadingThe quick read
Latest quote·Oct 12
Net selling: insiders sold $9.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $9.8M and bought $0 of CZR stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. The largest was Yunker, Bret (Chief Financial Officer), who sold $6.2M. The latest filing was on Sep 16, 2026.
None. No member of Congress disclosed a CZR trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Balyasny
$138.2M
added
Sells/Trims (2)
Citadel
$53.3M
trimmed
AQR
$48.0M
trimmed
No tracked top-trader positions in CZR right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 28, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.04 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | -$0.30 / $0.04Alpha Vantage | -$0.34 miss | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | -$0.40 / -$0.13Alpha Vantage | -$0.27 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 17, 2026 | -$1.23 / -$0.12Alpha Vantage | -$1.11 miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 28, 2025 | -$0.26 / $0.08Alpha Vantage | -$0.34 miss | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 29, 2025 | -$0.20 / $0.09Alpha Vantage | -$0.29 miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | -$0.48 / -$0.18Alpha Vantage | -$0.30 miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 25, 2025 | -$0.47 / $0.07Alpha Vantage | -$0.54 miss | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 29, 2024 | -$0.04 / $0.21Alpha Vantage | -119.05% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
-$0.07 to $0.23
Revenue expected
15 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
This company is not yet profitable.
Valuation
Quality
Growth
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
